TWOEquity · Weekly research terminal

4153

DIVA Laboratories, Ltd.

TW Healthcare Diagnostics & Research

Latest week
14 Aug 2026
Weekly close
33.00 TWD
Fair value
34.35 TWD
Next-week expectancy
Undecided 50.04%
Sharemaestro
Weekly Chart Pack Completed weekly market data · Independent research

TWO · Equity · Taiwan

4153

DIVA Laboratories, Ltd.

Healthcare Diagnostics & Research

DIVA Laboratories, Ltd. engages in the research, development, manufacture, and sale of medical devices and computer peripherals worldwide. The company provides endo/surgical displays for hybrid and other types of OR applications; color and mono displays for radiology applications; and touch and embedded display, as well as industrial displays. DIVA Laboratories, Ltd. was founded in 1984 and is headquartered in New Taipei City, Taiwan.

Last updated
14 Aug 2026
Exchange
Taipei Exchange · TWO
Sector
Healthcare
Industry
Diagnostics & Research
Currency
TWD
Market capitalisation
1,936,044,032
Fair value reference
34.35
Next-week expectancy
Undecided · 50.04%

Over the latest 12 completed weeks ending 2026-08-14, 4153 rose 10.96%, moving from 29.74 to 33.00. The latest weekly close is above the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -28.84 and has improved across the 12-week window. Market Dynamics is 1.18 on the latest week. Next-week expectancy is undecided at 50.04% based on similar historical setup states.

Week Ending
14 Aug 2026
Latest Close
33.00
12-Week Change
10.96%
Trend Signal
Inactive
Next-Week Expectancy
Undecided 50.04%
Signal Weeks
0 of 12

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
14 Aug 2026
Latest Close
33.00
12-Week Change
10.96%
Trend Signal
Inactive
Next-Week Expectancy
Undecided 50.04%
Signal Weeks
0 of 12
Vs Trend Line
Above
Vs Fair Value
Below
Relative Strength
-28.84
Market Dynamics
1.18

Over the latest 12 completed weeks ending 2026-08-14, 4153 rose 10.96%, moving from 29.74 to 33.00. The latest weekly close is above the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -28.84 and has improved across the 12-week window. Market Dynamics is 1.18 on the latest week. Next-week expectancy is undecided at 50.04% based on similar historical setup states.

Industry Peers

Taiwan equities in Diagnostics & Research

Stock Exchange Week Open High Low Close Change
6847 Puriblood Medical Co., Ltd. TWO 14 Aug 2026 77.70 81.40 75.80 79.30 2.06%
6939 TFBS Bioscience Inc. TWO 14 Aug 2026 19.50 20.00 18.70 19.65 0.77%
7595 Pharmigene, Inc. TWO 14 Aug 2026 7.20 7.36 6.90 7.25 0.69%
1784 BIONET Corp. TWO 14 Aug 2026 60.20 62.90 60.20 60.60 0.66%
4160 Genetics Generation Advancement Corp. TWO 14 Aug 2026 40.15 41.00 39.40 39.80 -0.87%
6615 Sofiva Genomics Co.,Ltd. TWO 14 Aug 2026 34.20 34.60 33.45 33.75 -1.32%
6645 Kim Forest Enterprise Co., Ltd. TAI 14 Aug 2026 13.55 13.60 13.10 13.25 -2.21%
6661 Welgene Biotech Co.,Ltd. TWO 14 Aug 2026 17.60 17.60 16.00 16.75 -4.83%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.

Evidence context